» Articles » PMID: 26796672

Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease

Overview
Date 2016 Jan 23
PMID 26796672
Citations 132
Authors
Affiliations
Soon will be listed here.
Abstract

In this article, we review the biology and physiological importance of transforming growth factor-β (TGF-β) to homeostasis in the respiratory system, its importance to innate and adaptive immune responses in the lung, and its pathophysiological role in various chronic pulmonary diseases including pulmonary arterial hypertension, chronic obstructive pulmonary disease, asthma, and pulmonary fibrosis. The TGF-β family is responsible for initiation of the intracellular signaling pathways that direct numerous cellular activities including proliferation, differentiation, extracellular matrix synthesis, and apoptosis. When TGF-β signaling is dysregulated or essential control mechanisms are unbalanced, the consequences of organ and tissue dysfunction can be profound. The complexities and myriad checkpoints built into the TGF-β signaling pathways provide attractive targets for the treatment of these disease states, many of which are currently being investigated. This review focuses on those aspects of TGF-β biology that are most relevant to pulmonary diseases and that hold promise as novel therapeutic targets.

Citing Articles

The histone demethylase KDM6B links obstructive sleep apnea to idiopathic pulmonary fibrosis.

Han S, Huang J, Yang C, Feng J, Wang Y FASEB J. 2025; 39(1):e70306.

PMID: 39781582 PMC: 11712539. DOI: 10.1096/fj.202402813R.


Oxylipin Profiling of Airway Structural Cells Is Unique and Modified by Relevant Stimuli.

Kahnamoui S, Winter T, Lloyd D, Halayko A, Mookherjee N, Aukema H J Proteome Res. 2025; 24(2):672-684.

PMID: 39752600 PMC: 11812602. DOI: 10.1021/acs.jproteome.4c00775.


Pulmonary exposure to renewable diesel exhaust particles alters protein expression and toxicity profiles in bronchoalveolar lavage fluid and plasma of mice.

McCarrick S, Malmborg V, Gren L, Danielsen P, Tuner M, Palmberg L Arch Toxicol. 2024; 99(2):797-814.

PMID: 39739031 PMC: 11775017. DOI: 10.1007/s00204-024-03915-y.


Toxicogenomic assessment of in vitro macrophages exposed to profibrotic challenge reveals a sustained transcriptomic immune signature.

Morikka J, Federico A, Mobus L, Inkala S, Pavel A, Sani S Comput Struct Biotechnol J. 2024; 25:194-204.

PMID: 39430886 PMC: 11490883. DOI: 10.1016/j.csbj.2024.10.010.


Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism.

Li X, Liu Y, Tang Y, Xia Z Front Immunol. 2024; 15:1474688.

PMID: 39386212 PMC: 11461261. DOI: 10.3389/fimmu.2024.1474688.


References
1.
Chen X, Wang H, Liao H, Hu W, Gewin L, Mernaugh G . Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling. J Clin Invest. 2014; 124(8):3295-310. PMC: 4109532. DOI: 10.1172/JCI71668. View

2.
Lin X, Duan X, Liang Y, Su Y, Wrighton K, Long J . PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell. 2006; 125(5):915-28. PMC: 6309366. DOI: 10.1016/j.cell.2006.03.044. View

3.
Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, Malmstrom A . Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest. 1993; 92(2):632-7. PMC: 294895. DOI: 10.1172/JCI116631. View

4.
West J, Fagan K, Steudel W, Fouty B, Lane K, Harral J . Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res. 2004; 94(8):1109-14. DOI: 10.1161/01.RES.0000126047.82846.20. View

5.
Crawford S, Stellmach V, Murphy-Ullrich J, Ribeiro S, Lawler J, Hynes R . Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 1998; 93(7):1159-70. DOI: 10.1016/s0092-8674(00)81460-9. View